NAMPT抑制剂-接头2
2241014-82-2
|
NAMPT抑制剂-接头1
2241019-57-6
|
CPA抑制剂
223532-02-3
|
SP 600125, negative control
54642-23-8
|
SIRT5抑制剂
2166487-21-2
|
TrkA抑制剂
388626-12-8
|
Btk抑制剂1
1412418-47-3
|
FAAH抑制剂1
326866-17-5
|
IRAK抑制剂4
1012104-68-5
|
1-{[1-(propan-2-yl)-1H-pyrazol-5-yl]methyl}cyclopropan-1-ol
2229392-26-9
|
L-Alanine, N-1-naphthalenyl-, [(2,4-dimethoxyphenyl)methylene]hydrazide
344912-24-9
|
Methanimidamide, N,N-dimethyl-Na(2)-[1,2,3]triazolo[1,5-a]quinoxalin-4-yl-
124573-96-2
|
4-[[4-(Aminomethyl)phenyl]methoxy]-6-(trifluoromethyl)-2-pyrimidinamine
913817-53-5
|
1-(Methoxymethyl)-2,2-dimethylcyclopropan-1-amine
2228797-12-2
|
6,7,8,9-Tetrahydro-1-methyl[1,2,4]triazolo[4,3-a]quinazolin-5(3H)-one
115102-48-2
|
6-Cyclopropyl-2-[1-(pyrazine-2-carbonyl)piperidin-4-yl]-1,8-naphthyridine
2742039-69-4
|
N-methyl-1-{[1-(propan-2-yl)-1H-pyrazol-5-yl]methyl}cyclopropan-1-amine
2228180-32-1
|
(4,5,6,7-Tetrahydro-1-benzothiophen-2-yl)methanesulfonyl fluoride
2228489-25-4
|
2-{[2-(4-Methoxyphenyl)ethyl](methyl)amino}-3-methyl-3,4-dihydroquinazolin-4-one
2742063-65-4
|